Baxter Bros Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
40,350
-459
-1% -$107K 1.19% 25
2026
Q1
$9.98M Sell
40,809
-420
-1% -$97.8K 1.23% 25
2025
Q4
$8.53M Sell
41,229
-1,290
-3% -$255K 0.99% 29
2025
Q3
$7.88M Buy
42,519
+320
+0.8% +$54.8K 0.91% 29
2025
Q2
$6.45M Sell
42,199
-3,584
-8% -$551K 0.79% 32
2025
Q1
$7.59M Sell
45,783
-2,841
-6% -$445K 1% 27
2024
Q4
$7.03M Sell
48,624
-2,419
-5% -$375K 0.92% 30
2024
Q3
$8.27M Sell
51,043
-1,814
-3% -$289K 1.08% 25
2024
Q2
$7.73M Sell
52,857
-4,295
-8% -$639K 1.01% 26
2024
Q1
$9.04M Sell
57,152
-768
-1% -$122K 1.16% 23
2023
Q4
$9.08M Sell
57,920
-1,567
-3% -$240K 1.26% 23
2023
Q3
$9.27M Sell
59,487
-1,239
-2% -$204K 1.41% 21
2023
Q2
$10.1M Buy
60,726
+637
+1% +$103K 1.49% 20
2023
Q1
$9.31M Sell
60,089
-841
-1% -$136K 1.46% 19
2022
Q4
$10.8M Sell
60,930
-921
-1% -$159K 1.77% 17
2022
Q3
$10.1M Buy
61,851
+11,616
+23% +$1.97M 1.79% 18
2022
Q2
$8.92M Sell
50,235
-196
-0.4% -$34.9K 1.6% 17
2022
Q1
$8.94M Sell
50,431
-943
-2% -$160K 1.34% 22
2021
Q4
$8.79M Sell
51,374
-613
-1% -$100K 1.27% 24
2021
Q3
$8.4M Sell
51,987
-547
-1% -$93.3K 1.34% 24
2021
Q2
$8.65M Buy
52,534
+2,172
+4% +$360K 1.37% 23
2021
Q1
$8.28M Buy
50,362
+653
+1% +$106K 1.42% 21
2020
Q4
$7.82M Buy
49,709
+1,854
+4% +$274K 1.48% 20
2020
Q3
$7.13M Buy
47,855
+428
+0.9% +$63.3K 1.54% 19
2020
Q2
$6.67M Sell
47,427
-3,187
-6% -$464K 1.57% 18
2020
Q1
$6.64M Buy
50,614
+4,884
+11% +$693K 1.72% 17
2019
Q4
$6.67M Sell
45,730
-1,860
-4% -$252K 1.39% 25
2019
Q3
$6.16M Buy
47,590
+461
+1% +$60.7K 1.39% 26
2019
Q2
$6.56M Buy
47,129
+886
+2% +$123K 1.5% 23
2019
Q1
$6.46M Buy
46,243
+1,228
+3% +$164K 1.51% 22
2018
Q4
$5.81M Buy
45,015
+5,905
+15% +$824K 1.58% 19
2018
Q3
$5.4M Sell
39,110
-2,099
-5% -$279K 1.3% 23
2018
Q2
$5M Sell
41,209
-736
-2% -$91.8K 1.34% 25
2018
Q1
$5.38M Sell
41,945
-12
-0% -$1.62K 1.47% 21
2017
Q4
$5.86M Sell
41,957
-1,209
-3% -$168K 1.61% 16
2017
Q3
$5.61M Buy
43,166
+1,005
+2% +$133K 1.61% 17
2017
Q2
$5.58M Sell
42,161
-171
-0.4% -$21.8K 1.68% 15
2017
Q1
$5.27M Sell
42,332
-220
-0.5% -$26.3K 1.65% 16
2016
Q4
$4.9M Sell
42,552
-140
-0.3% -$16.2K 1.58% 19
2016
Q3
$5.04M Sell
42,692
-5,529
-11% -$671K 1.7% 17
2016
Q2
$5.85M Buy
+48,221
New +$5.48M 2.05% 16
2015
Q4
$4.98M Buy
48,481
+2,529
+6% +$254K 1.85% 16
2015
Q3
$4.48M Hold
45,952
1.64% 20
2015
Q2
$4.48M Sell
45,952
-175
-0.4% -$17.5K 1.64% 20
2015
Q1
$4.64M Sell
46,127
-49
-0.1% -$4.98K 1.69% 20
2014
Q4
$4.83M Sell
46,176
-156
-0.3% -$16.4K 1.75% 20
2014
Q3
$4.94M Buy
46,332
+1,502
+3% +$156K 1.92% 19
2014
Q2
$4.69M Sell
44,830
-223
-0.5% -$22.5K 1.93% 19
2014
Q1
$4.43M Buy
45,053
+601
+1% +$55.7K 2.01% 16
2013
Q4
$4.07M Buy
44,452
+1,207
+3% +$111K 1.91% 19
2013
Q3
$3.75M Buy
43,245
+1,766
+4% +$158K 2.05% 16
2013
Q2
$3.56M Buy
+41,479
New +$3.52M 2.16% 14

Other funds holding JNJ

Baxter Bros Inc's JNJ Position: Q2 2026 in Review

Baxter Bros Inc reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, selling an estimated $107K and leaving 40,350 shares worth $10.2M. The position accounts for 1.19% of the portfolio, ranked #25.

Baxter Bros Inc first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.8M in Q4 2022. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Baxter Bros Inc held 40,350 shares of Johnson & Johnson worth $10.2M as of Q2 2026.
  • Baxter Bros Inc sold 459 Johnson & Johnson shares in Q2 2026, an estimated $107K.
  • Johnson & Johnson made up 1.19% of Baxter Bros Inc's portfolio in Q2 2026, its #25 holding.
  • Baxter Bros Inc first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Baxter Bros Inc's Johnson & Johnson position peaked at $10.8M in Q4 2022.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.